Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.980
+0.060 (3.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
LIXT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 3.14 | 4.19 | 4.96 | 4.98 | 2.04 | 1.67 | |
| Research & Development | 0.84 | 0.9 | 1.35 | 1.74 | 1.22 | 0.82 | |
| Operating Expenses | 3.99 | 5.09 | 6.31 | 6.72 | 3.27 | 2.49 | |
| Operating Income | -3.99 | -5.09 | -6.31 | -6.72 | -3.27 | -2.49 | |
| Interest Expense | -0.02 | -0.02 | -0.01 | -0.01 | -0 | - | |
| Interest & Investment Income | 0.01 | 0.02 | 0.01 | 0 | 0 | 0.05 | |
| Currency Exchange Gain (Loss) | -0 | 0 | -0 | -0 | 0 | - | |
| EBT Excluding Unusual Items | -4 | -5.09 | -6.31 | -6.73 | -3.26 | -2.44 | |
| Pretax Income | -4 | -5.09 | -6.31 | -6.73 | -3.26 | -2.44 | |
| Net Income | -4 | -5.09 | -6.31 | -6.73 | -3.26 | -2.44 | |
| Net Income to Common | -4 | -5.09 | -6.31 | -6.73 | -3.26 | -2.44 | |
| Shares Outstanding (Basic) | 2 | 2 | 2 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 1 | 1 | 1 | |
| Shares Change (YoY) | 27.20% | 21.10% | 17.41% | 19.48% | 0.92% | 14.04% | |
| EPS (Basic) | -1.78 | -2.66 | -3.99 | -4.99 | -2.90 | -2.18 | |
| EPS (Diluted) | -1.78 | -2.66 | -3.99 | -4.99 | -2.90 | -2.18 | |
| Free Cash Flow | -3.47 | -4.29 | -4.61 | -4.14 | -2.13 | -1.67 | |
| Free Cash Flow Per Share | -1.54 | -2.24 | -2.92 | -3.07 | -1.89 | -1.50 | |
| EBIT | -3.99 | -5.09 | -6.31 | -6.72 | -3.27 | -2.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.